| New tumor markers: CA125 and beyond RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International Journal of Gynecologic Cancer 15 (Suppl 3), 2005 | 681 | 2005 |
| Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus RG Moore, AK Brown, MC Miller, D Badgwell, Z Lu, WJ Allard, CO Granai, ... Gynecologic oncology 110 (2), 196-201, 2008 | 379 | 2008 |
| Early detection of ovarian cancer D Badgwell, RC Bast Jr Disease markers 23 (5-6), 397-410, 2007 | 378 | 2007 |
| Development of a multimarker assay for early detection of ovarian cancer Z Yurkovetsky, S Skates, A Lomakin, B Nolen, T Pulsipher, F Modugno, ... Journal of Clinical Oncology 28 (13), 2159-2166, 2010 | 358 | 2010 |
| Prevention and early detection of ovarian cancer: mission impossible? RC Bast, M Brewer, C Zou, MA Hernandez, M Daley, R Ozols, K Lu, Z Lu, ... Cancer Prevention, 91-100, 2007 | 177 | 2007 |
| IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain L Zhang, DB Badgwell, JJ Bevers, K Schlessinger, PJ Murray, DE Levy, ... Molecular and cellular biochemistry 288, 179-189, 2006 | 105 | 2006 |
| Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment D Badgwell, Z Lu, L Cole, H Fritsche, EN Atkinson, E Somers, J Allard, ... Gynecologic oncology 106 (3), 490-497, 2007 | 103 | 2007 |
| Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage … CH Clarke, C Yip, D Badgwell, ET Fung, KR Coombes, Z Zhang, KH Lu, ... Gynecologic oncology 122 (3), 548-553, 2011 | 100 | 2011 |
| The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways DB Badgwell, Z Lu, K Le, F Gao, M Yang, GK Suh, JJ Bao, P Das, ... Oncogene 31 (1), 68-79, 2012 | 98 | 2012 |
| Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers Y Yu, R Luo, Z Lu, WW Feng, D Badgwell, JP Issa, DG Rosen, J Liu, ... Methods in Enzymology 407, 455-468, 2006 | 83 | 2006 |
| Urinary levels of Bcl-2 are elevated in ovarian cancer patients NS Anderson, Y Bermudez, D Badgwell, R Chen, SV Nicosia, RC Bast Jr, ... Gynecologic oncology 112 (1), 60-67, 2009 | 63 | 2009 |
| Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer AR Simmons, CH Clarke, DB Badgwell, Z Lu, LJ Sokoll, KH Lu, Z Zhang, ... International Journal of Gynecologic Cancer 26 (6), 2016 | 47 | 2016 |
| Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation–induced murine skin tumors DB Badgwell, CM Walker, WT Baker, FM Strickland Molecular Carcinogenesis: Published in cooperation with the University of …, 2004 | 20 | 2004 |
| Proteomics discovery of urinary biomarkers for early stage ovarian cancer C Clarke, TA Dang, D Badgwell, E Fung, R Bast Cancer Research 67 (9_Supplement), 594-594, 2007 | 6 | 2007 |
| Use of a panel of proteomic markers to improve the sensitivity of CA125 for detecting stage I epithelial ovarian cancer CH Clarke, ET Fung, C Yip, C Joy, D Badgwell, KR Coombes, Z Zhang, ... Journal of Clinical Oncology 26 (15_suppl), 5542-5542, 2008 | 5 | 2008 |
| A novel multiple biomarker assay for the detection of ovarian carcinoma RG Moore, AK Brown, CM Miller, D Badgwell, Z Lu, T Verch, KH Lu, ... Journal of Clinical Oncology 24 (18_suppl), 5023-5023, 2006 | 3 | 2006 |
| Utility of a novel serum tumor biomarker HE4 in patients with uterine cancer RG Moore, AK Brown, CM Miller, D Badgwell, Z Lu, T Verch, JW Allard, ... Journal of Clinical Oncology 24 (18_suppl), 5036-5036, 2006 | 2 | 2006 |
| Re-expression of the tumor suppressor gene ARHI decreases ovarian cancer cell motility by inhibiting Stat3 signaling D Badgwell, Z Lu, RZ Luo, Y Yu, J Bao, WLS Liao, RC Bast Cancer Research 67 (9_Supplement), 476-476, 2007 | 1 | 2007 |
| Re-expression of the tumor suppressor gene ARHI suppresses ovarian cancer cell motility through inhibition of Stat3 and the Rho/ROCK signaling Z Lu, D Badgwell, K Le, G Suh, P Das, M Andreeff, A Ahmed, W Liao, ... CANCER RESEARCH 69, 2009 | | 2009 |
| Abstract# 3894: Re-expression of the tumor suppressor gene ARHI suppresses ovarian cancer cell motility through inhibition of Stat3 and the Rho/ROCK signaling Z Lu, D Badgwell, K Le, G Suh, P Das, M Andreeff, A Ahmed, W Liao, ... Cancer Research 69 (9_Supplement), 3894-3894, 2009 | | 2009 |
